Impairment of chemical clearance is relevant to the pathogenesis of refractory reflux oesophagitis

被引:50
作者
Frazzoni, Marzio [1 ]
Bertani, Helga [2 ]
Manta, Raffaele [2 ]
Mirante, Vincenzo Giorgio [2 ]
Frazzoni, Leonardo [3 ]
Conigliaro, Rita [2 ]
Melotti, Gianluigi [4 ]
机构
[1] Baggiovara Hosp, Digest Pathophysiol Unit, Modena, Italy
[2] Baggiovara Hosp, Digest Endoscopy Unit, Modena, Italy
[3] Univ Bologna, Dept Med & Surg Sci, Bologna, Italy
[4] Baggiovara Hosp, Dept Gen Surg, Modena, Italy
关键词
Impedance-pH monitoring; Oesophageal chemical clearance; PPI; Refractory GERD; Refractory reflux oesophagitis; PROTON PUMP INHIBITORS; GASTROESOPHAGEAL-REFLUX; NORMAL VALUES; PATHOPHYSIOLOGICAL CHARACTERISTICS; INTRALUMINAL IMPEDANCE; PH-IMPEDANCE; DISEASE; ACID; ARTICLE; ABNORMALITIES;
D O I
10.1016/j.dld.2014.03.005
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: The pathophysiological mechanisms underlying proton pump inhibitor-refractory reflux oesophagitis has been scarcely studied. Aims: To assess impedance-pH parameters relevant to the pathogenesis of refractory reflux oesophagitis. Methods: Cases referred for heartburn/regurgitation refractory to high-dosage proton pump inhibitors between January 2008 and December 2012 were reviewed and subdivided into refractory oesophagitis (29 patients, 72% males, median age 50 years), healed oesophagitis (18 patients, 67% males, median age 54 years), and non-erosive reflux disease (49 patients, 53% males, median age 42 years). On-therapy impedance-pH tracings were blindly re-analysed by one observer to assess gastric and oesophageal acid exposure time and chemical clearance as expressed by the post-reflux swallow-induced peristaltic wave index. Results: The median gastric and oesophageal acid exposure time did not differ among the three groups (35%, 34%, 41% and 1.2%, 0.7%, 0.8%, respectively; P > 0.05 for all comparisons). A normal oesophageal acid exposure time was found in two thirds of patients with refractory oesophagitis. The post-reflux swallow-induced peristaltic wave index was significantly lower in refractory oesophagitis (16%) than in healed oesophagitis (30%) and non-erosive reflux disease (29%) (P = 0.003). Conclusions: Refractory reflux oesophagitis is characterized by impairment of chemical clearance. Adequate acid suppression is found in the majority of patients who would likely not benefit from further proton pump inhibitor dose escalation. (C) 2014 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:596 / 602
页数:7
相关论文
共 40 条
[1]   Pro: Impedance Testing Is Useful in the Management of GERD [J].
Blondeau, Kathleen ;
Tack, Jan .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2009, 104 (11) :2664-2666
[2]   Review article: the pathophysiology of gastro-oesophageal reflux disease [J].
Boeckxstaens, G. E. E. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2007, 26 (02) :149-160
[3]   Reproducibility of multichannel intraluminal electrical impedance monitoring of gastroesophageal reflux [J].
Bredenoord, AJ ;
Weusten, BLAM ;
Timmer, R ;
Smout, AJPM .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (02) :265-269
[4]   Proton pump inhibitor resistance, the real challenge in gastro-esophageal reflux disease [J].
Cicala, Michele ;
Emerenziani, Sara ;
Guarino, Michele Pier Luca ;
Ribolsi, Mentore .
WORLD JOURNAL OF GASTROENTEROLOGY, 2013, 19 (39) :6529-6535
[5]   Review article: intra-oesophageal impedance monitoring for the assessment of bolus transit and gastro-oesophageal reflux [J].
Conchillo, J. M. ;
Smout, A. J. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2009, 29 (01) :3-14
[6]   Pathophysiological characteristics of the various forms of gastro-oesophageal reflux disease - Spectrum disease or distinct phenotypic presentations? [J].
Frazzoni, M. ;
Manno, M. ;
De Micheli, E. ;
Savarino, V. .
DIGESTIVE AND LIVER DISEASE, 2006, 38 (09) :643-648
[7]   Esophageal chemical clearance is impaired in gastro-esophageal reflux disease a 24-h impedance-pH monitoring assessment [J].
Frazzoni, M. ;
Manta, R. ;
Mirante, V. G. ;
Conigliaro, R. ;
Frazzoni, L. ;
Melotti, G. .
NEUROGASTROENTEROLOGY AND MOTILITY, 2013, 25 (05) :399-e295
[8]   Hiatal hernia is the key factor determining the lansoprazole dosage required for effective intra-oesophageal acid suppression [J].
Frazzoni, M ;
De Micheli, E ;
Grisendi, A ;
Savarino, V .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2002, 16 (05) :881-886
[9]   Laparoscopic fundoplication versus lansoprazole for gastro-oesophageal reflux disease. A pH-metric comparison [J].
Frazzoni, M ;
Grisendi, A ;
Lanzani, A ;
Melotti, G ;
De Micheli, E .
DIGESTIVE AND LIVER DISEASE, 2002, 34 (02) :99-104
[10]   Reflux patterns in patients with short-segment Barrett's oesophagus: a study using impedance-pH monitoring off and on proton pump inhibitor therapy [J].
Frazzoni, M. ;
Savarino, E. ;
Manno, M. ;
Melotti, G. ;
Mirante, V. G. ;
Mussetto, A. ;
Bertani, H. ;
Manta, R. ;
Conigliaro, R. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2009, 30 (05) :508-515